Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review
<b>Background</b>: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to prevent clotting, typically using unfractionated heparin (UFH). However, anticoagulation carries a bleeding risk, necessitating monitoring. Activated clotting time (ACT) is a commonly used monitoring t...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2025-07-01
|
| Serier: | Journal of Cardiovascular Development and Disease |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2308-3425/12/7/267 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
